Immune Cells Show Promise in Boosting Cancer Treatment for Acute Leukemia
27 Jan 2025
Acute myeloid leukemia (AML) is a formidable type of cancer that primarily targets the bone marrow and spreads into the bloodstream. With an incidence rate of four per 100,000 individuals annually in the U.S., AML has long posed a serious challenge in the medical community due to its aggressive nature...
Read More